Recognizing March 2025 As "colorectal Cancer Awareness Month" In The State Of Delaware.
Summary
SCR22 is a Senate Concurrent Resolution that recognizes March 2025 as "Colorectal Cancer Awareness Month" in Delaware. The resolution states that March is nationally observed for colorectal cancer awareness and emphasizes the importance of prevention, screening, and early detection. It cites Delaware-specific and national statistics showing the disease’s significant impact, including its status as the third leading cause of cancer-related deaths in the state and the disproportionate mortality rate among African Americans.
The resolution also highlights risk factors and screening options, noting that regular screenings are recommended beginning at age 45 for many individuals and that colonoscopies and FIT kits can help detect or prevent colorectal cancer by identifying precancerous polyps early. It further notes that most preventive screenings are covered by insurance and that colorectal cancer is highly treatable when caught early. The measure is primarily educational and commemorative, encouraging Delawareans to learn about prevention and early detection rather than creating a new program or regulatory requirement.
Impact
SCR22 does not amend the Delaware Code or create new statutory duties, funding, or enforcement mechanisms. Its legal effect is limited to a formal legislative recognition of March 2025 as Colorectal Cancer Awareness Month and a public-health message encouraging education and screening. The resolution may help elevate awareness among residents, healthcare providers, and advocacy groups, but it does not directly change insurance coverage, screening mandates, or treatment requirements.
Sentiment
The sentiment around the resolution appears strongly supportive and noncontroversial. It passed the Senate Third Reading unanimously, 19-0, indicating broad bipartisan agreement on the importance of cancer awareness and prevention. No committee transcripts or recorded debate are provided, and the House vote information shows no opposing votes recorded in the available history.
Contention
There is little to no visible contention in the available record. The resolution’s focus on public awareness, early detection, and health education is generally consensus-driven. The only potentially sensitive point is the bill’s emphasis on racial disparities in colorectal cancer mortality, which highlights unequal health outcomes among African Americans, but the text presents this as a public-health concern rather than a policy dispute. No legislators or stakeholder groups are identified as opposing the measure.